Pulmonary disease, lower respiratory tract infection, and pneumonia are the largest causes of morbidity and mortality in individuals with Down syndrome (DS), but whether pulmonary diagnoses in children with DS are common and occur independently of cardiac disease and pulmonary hypertension (PH) is unknown. Cardiopulmonary phenotypes were examined in a cohort of 1248 children with DS. Aptamer-based proteomic analysis of blood was performed in a subset (n = 120) of these children. By the age of 10 years, half of the patients in this cohort (n = 634, 50.8%) had co-occurring pulmonary diagnoses. That proteins and related pathways were distinct between children with pulmonary diagnoses and those with cardiac disease and/or PH may indicate that pulmonary diagnoses appear to occur independently of cardiac disease and PH. Heparin sulfate-glycosaminoglycandegradation, nicotinate metabolism, and elastic fiber formation were ranked highest in the group with pulmonary diagnoses.
FreemanSBTaftLFDooleyKJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet. 1998;80:213-217.
2.
BittlesAHBowerCHussainRGlassonEJ.The four ages of Down syndrome. Eur J Public Health. 2007;17(2):221-225.
3.
FudgeJCJrLiSJaggersJ, et al. Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database. Pediatrics. 2010;126(2):315-322.
4.
EvansJMDharmarMMeierhenryEMarcinJPRaffGW.Association between Down syndrome and in-hospital death among children undergoing surgery for congenital heart disease: a US population-based study. Circ Cardiovasc Qual Outcomes. 2014;7(3):445-452.
5.
YangQRasmussenSAFriedmanJM.Mortality associated with Down’s syndrome in the USA from 1983 to 1997: a population-based study. Lancet. 2002;359:1019-1025.
6.
JoffreCLesageFBustarretOHubertPOualhaM.Children with Down syndrome: clinical course and mortality-associated factors in a French medical paediatric intensive care unit. J Paediatr Child Health. 2016;52(6):595-599.
7.
CliftAKCouplandCACKeoghRHHemingwayHHippisley-CoxJ.COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults. Ann Intern Med. 2021;174:572-576.
8.
VillaniERCarfìADi PaolaA, et al. Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series. Am J Med Genet A. 2020;182(12):2964-2970.
9.
BloemersBLvan FurthAMWeijermanME, et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis–a prospective birth-cohort study. Pediatrics. 2007;120(4):e1076-81.
10.
DeutschGHYoungLRDeterdingRR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007;176:1120-1128.
11.
BushDAbmanSHGalambosC.Prominent intrapulmonary bronchopulmonary anastomoses and abnormal lung development in infants and children with Down syndrome. J Pediatr. 2017;180:156-162.
12.
PageDVStockerJT.Anomalies associated with pulmonary hypoplasia. Am Rev Respir Dis. 1982;125:216-221.
13.
CooneyTPThurlbeckWM.Pulmonary hypoplasia in Down’s syndrome. N Engl J Med. 1982;307:1170-1173.
14.
BushDGalambosCIvyDDAbmanSHWolter-WarmerdamKHickeyF.Clinical characteristics and risk factors for developing pulmonary hypertension in children with Down syndrome. J Pediatr. 2018;202:212-219.e2.
15.
WattsRVyasH.An overview of respiratory problems in children with Down’s syndrome. Arch Dis Child. 2013;98(10):812-817.
16.
McDowellKMCravenDI.Pulmonary complications of Down syndrome during childhood. J Pediatr. 2011;158:319-325.
17.
JacksonAMaybeeJMoranMKWolter-WarmerdamKHickeyF.Clinical characteristics of dysphagia in children with Down syndrome. Dysphagia. 2016;31(5):663-671.
18.
BushDWolter-WarmerdamKWagnerBD, et al. EXPRESS: angiogenic profile identifies pulmonary hypertension in children with Down syndrome. Pulm Circ. 2019;19:2045894019866549.
19.
Obermann-BorstSAvan DrielLMHelbingWA, et al. Congenital heart defects and biomarkers of methylation in children: a case-control study. Eur J Clin Invest. 2011;41(2):143-150.
20.
SullivanKDEvansDPandeyA, et al. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep. 2017;7:14818.
21.
HarrisPATaylorRThielkeRPayneJGonzalezNCondeJG.Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
22.
HickeyFWolter-WarmerdamKHickeyEYoonJDanielsD.Pediatric comorbidities and medical complications identified in children with Down syndrome. J Down Syndr Chr Abnorm. 2017;3:124.
23.
GoldLAyersDBertinoJ, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. 2010;5:e15004.
KhatriPSirotaMButteAJ.Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol. 2012;8(2):e1002375.
31.
PooleWGibbsDLShmulevichIBernardBKnijnenburgTA.Combining dependent P-values with an empirical adaptation of Brown’s method. Bioinformatics. 2016;32:i430-i436.
32.
MechamRP.Elastin in lung development and disease pathogenesis. Matrix Biol. 2018;73:6-20.
33.
BlackPNChingPSBeaumontBRanasingheSTaylorGMerrileesMJ.Changes in elastic fibres in the small airways and alveoli in COPD. Eur Respir J. 2008;31(5):998-1004.
34.
LiTZouC.The role of deubiquitinating enzymes in acute lung injury and acute respiratory distress syndrome. Int J Mol Sci. 2020;21:4842.
35.
QiXGurungPMalireddiRK, et al. Critical role of caspase-8-mediated IL-1 signaling in promoting Th2 responses during asthma pathogenesis. Mucosal Immunol. 2017;10(1):128-138.
36.
MocarskiESUptonJWKaiserWJ.Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol. 2011;12:79-88.
37.
BloemersBLBroersCJBontLWeijermanMEGemkeRJvan FurthAM.Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect. 2010;12(11):799-808.
38.
ChinerELlombartMVallsJ, et al. Association between obstructive sleep apnea and community-acquired pneumonia. PLoS ONE. 2016;11(4):e0152749.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
